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INTRODUCTION
Vague initial presentations and ambiguous laboratory findings 
often make it difficult to diagnose amyotrophic lateral sclerosis 
(ALS) at an early stage. Although 70% of familial ALS and 10% 
of sporadic ALS cases are confirmed genetically, familial ALS 
accounts for only 5–10% of all cases of ALS, and the testable 
genes may vary according to laboratory settings.1,2 Therefore, 
ALS is often misdiagnosed as other diseases and treated inap-
propriately at the initial stage. Further, unnecessary treatments 
are likely to further delay the diagnosis of ALS.3,4
Various initial presenting symptoms of ALS are generally 
classified into limb- and bulbar-dominant types. Less than 5% 
of the patients are known to have trunk or respiratory involve-
ment at the initial stage.5 However, actual clinical data on these 
initial presentations are currently insufficient. Here, we ana-
lyze the clinical data of a large cohort of ALS patients with re-
spect to initial symptoms and progress from symptom onset to 
diagnosis to provide useful insights for clinical practice.
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Purpose: One obstacle in early diagnosis of amyotrophic lateral sclerosis (ALS) is its vague initial presentation, which is generally 
classified into limb- and bulbar-dominant types and may be mistaken for other musculoskeletal conditions. We analyzed clinical 
data from patients in relation to their initial presentation and prognosis from symptom onset to diagnosis.
Materials and Methods: We retrospectively analyzed the medical records of patients with ALS who were admitted for pulmonary 
rehabilitation between January 2007 and December 2019. We collected data on time of onset, initial presenting symptoms, un-
necessary operations due to misdiagnosis, and the time between symptom onset and final diagnosis of ALS.
Results: Among 500 patients, unnecessary operations were performed in 43 patients. The median durations between symptom 
onset and ALS diagnosis for patients with and without operations were 11 and 9 months, respectively (p=0.008). 67.0%, 28.8%, 
and 4.2% of the patients presented with limb-, bulbar-, and respiratory-dominant symptoms, respectively, as initial presentations. 
The median ages at symptom onset were significantly different for limb-, bulbar-, and respiratory-dominant onset (57.5, 60.6, and 
66.7 years, respectively; p<0.001). Compared to the other two types, patients with the respiratory-dominant onset were all male and 
showed higher rate of emergent endotracheal intubation before ALS diagnosis. 
Conclusion: Inappropriate operations significantly delayed the diagnosis of ALS. Respiratory difficulty can account for a signifi-
cant proportion among initial presentations in ALS. Compared to limb- and bulbar-dominant types, respiratory-dominant onset 
appears to show male predominance, older age at symptom onset, and poor respiratory prognosis.
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As of December 2019, the medical records of 500 consecutive 
patients with ALS who were hospitalized at the Pulmonary 
Rehabilitation Center of Gangnam Severance Hospital from 
January 2007 were retrospectively analyzed. Diagnosis of ALS 
was essentially based on the revised El Escorial criteria, and 
the patients who fit the criteria for definite and probable ALS 
were included in this study. When the diagnosis was uncer-
tain, diagnostic evaluations were repeated during the follow-
up period in consultation with an experienced neurologist, if 
necessary. Patients with motor neuron diseases whose diag-
noses were not confirmed as ALS were excluded. Patients with 
inaccurate data on initial presenting symptoms, onset time, or 
time of diagnostic confirmation were also excluded from the 
analysis. During that period, a total of 519 patients were admit-
ted, but the medical records of 500 patients were used for 
analysis because 19 patients had insufficient medical infor-
mation. The patients who were included in this study were all 
native Korean people.
Collected information of the patients
We collected information on onset time, symptoms of initial 
presentation, time of diagnosis, and surgical treatments per-
formed in relation to the presenting symptoms between the 
time of symptom development and diagnosis. The initial pre-
senting symptoms were classified into three types according to 
the major symptoms at the initial presentation: 1) limb-domi-
nant onset, 2) bulbar-dominant onset, and 3) respiratory-
dominant onset. Limb-dominant symptoms included weak-
ness and/or fatigue of the upper or lower extremities and loss 
of hand dexterity. Bulbar-dominant symptoms included dys-
phagia, dysarthria, drooling, and chewing difficulty. Symptoms 
of dyspnea, exertional dyspnea, and orthopnea were regarded 
as respiratory-dominant symptoms. We also collected data on 
surgical interventions received by the patients. No operations 
have been proven to be treatments for ALS until recently. How-
ever, some patients with ALS-related symptoms received sur-
gical treatments prior to confirmation of ALS or after misdiagno-
sis. We defined these interventions as inappropriate operations. 
This study was approved by the Institutional Review Board of 
Gangnam Severance Hospital (3-2017-0393).
Statistical analysis
For comparison of the frequency of each study group, a chi-
square test was used. To compare median and mean values 
between two groups, Mann-Whitney (for non-normal distri-
bution) and independent t-tests (for normal distribution) were 
performed, respectively. Because the number of subjects with 
respiratory-dominant onset was relatively low, the Kruskal-
Wallis test was performed to compare the three types of initial 
presentations, and Bonferroni correction was used for post 
hoc analysis. All statistical analyses were performed using IBM 
SPSS Statistics 23 (IBM Corp., Armonk, NY, USA). 
RESULTS
The demographic characteristics of 500 patients are shown in 
Table 1. The average age at symptom onset was 57.9±11.9 years, 
and the mean duration from symptom onset to diagnosis of 
ALS was 12.7±11.9 months. Of the patients, 314 (62.8%) were 
male. Furthermore, 335 (67.0%) patients showed limb-domi-
nant onset, 144 (28.8%) patients had bulbar-dominant onset, 
and 21 (4.2%) patients had respiratory-dominant onset ac-
cording to the classification of initial presentation. Overall, 43 
(8.6%) patients received inappropriate surgical treatment in 
Table 1. Characteristics of the Study Subjects
Number (%) Onset age (ys)* p value Onset to diagnosis (months)* p value
Overall 500 57.9±11.9 12.7±11.9
Sex   0.593† 0.004†
Male 314 (62.8) 58.1±11.6 11.5±10.3
Female 186 (37.2) 57.5±12.6 14.9±14.0
Age (yr) 0.985†
<60 266 (53.2) 12.7±12.5
≥60 234 (46.8) 12.7±11.2
Onset type <0.001‡ 0.005‡
Limb 335 (67.0) 57.5 (15.9) 10.0 (13.0)
Bulbar 144 (28.8) 60.6 (14.1)   8.5 (10.0)
Respiratory 21 (4.2) 66.7 (14.0) 6.0 (7.0)
Operation   0.053§ 0.008§
With operation 43 (8.6) 61.8 (12.8) 11 (17)
Without operation 457 (91.4) 58.3 (16.3)   9 (12)
*Onset age and the period between onset to diagnosis are presented as means±standard deviations or medians (interquartile rage), †Independent t-test, ‡Krus-
kal-Wallis test, §Mann-Whitney U test.
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relation to the initial presenting symptoms after a misdiagno-
sis. A significant difference in onset age was not observed be-
tween male and female patients; however, the duration from 
symptom onset to ALS diagnosis was shorter for male patients 
than for female patients. There was no significant difference in 
the time from onset to diagnosis between patients who were 
aged <60 years and patients who were ≥60 years. No significant 
correlation was observed between onset age and diagnostic 
duration (correlation coefficient, -0.044; p=0.328; not shown 
in the table).
Furthermore, 62.7% (n=210) of the patients with limb-domi-
nant onset and 57.6% (n=83) of the patients with bulbar-domi-
nant onset were male; however, all 21 patients with respiratory-
dominant onset were male, which was statistically significant 
(p=0.001). Although only 1.5% of the patients with limb-domi-
nant onset and 4.9% of the patients with bulbar-dominant on-
set received emergent endotracheal intubation caused by acute 
ventilatory deterioration before ALS diagnosis, 15 of the 21 pa-
tients (71.4%) with respiratory-dominant onset underwent 
emergency endotracheal intubation before the diagnosis of 
ALS, which was significantly different (p<0.001). The median 
ages at symptom onset were 57.5 years for patients with limb-
dominant onset, 60.6 years for patients with bulbar-dominant 
onset, and 66.7 years for patients with respiratory-dominant 
onset. The limb-dominant group showed significant earlier 
onset than the other two groups. The duration between symp-
tom onset and diagnosis was significantly shorter in patients 
with respiratory-dominant onset, compared to patients with 
limb-dominant onset (Table 2).
The duration from symptom onset to diagnosis differed be-
tween the sexes depending on whether the patients with re-
spiratory-dominant onset were included or not. If the 21 pa-
tients with respiratory-dominant onset were excluded from 
the analysis, the duration from symptom onset to diagnosis in 
the other 479 patients would be 12.7±12.4 months in male pa-
tients and 13.1±11.5 months in female patients; this difference 
was not statistically significant (independent t-test; p=0.220, 
not shown in the table).
The operation sites of the 43 patients who received inappro-
priate surgical intervention in relation to the initial symptoms 
before the diagnosis of ALS are described in Table 3. Thirty-
eight patients underwent spinal surgeries, and four of them had 
multiple operations. Five patients received a carpal tunnel re-
lease operation, and one of them received a subsequent oper-
ation at the cervical spine. Cubital tunnel release was performed 
in one patient. None of the 43 patients showed any improve-
ment in their relevant symptoms despite undergoing surgical 
treatments. Among the 43 patients, 41 patients had limb-dom-
inant onset (12.3% of all patients with limb-dominant onset), 
and the other 2 patients had bulbar-dominant onset (1.4% of all 
patients with bulbar-dominant onset), a statistically significant 
difference (p<0.001). The two patients with bulbar-dominant 
onset received an operation at the cervical spine. No patients 
with respiratory-dominant onset underwent surgical treatment 
in relation to their initial presenting symptoms.
DISCUSSION
The U.S. Food and Drug Administration has approved riluzole 
and edaravone for the treatment of ALS. Although these drugs 
cannot change the final outcome of ALS, they are known to 
slow the progress of the disease6 and to increase tracheostomy-
free survival.7,8 For better prognosis and response, medication 
should be administered as early as possible.9 Therefore, an ac-
curate diagnostic evaluation is required at an early stage of the 
disease during which symptoms are ambiguous and vague.10 
If asymmetric distal limb weakness occurs in middle age, dur-
ing which ALS develops frequently, differential diagnosis for 
various musculoskeletal conditions, including degenerative 
spinal diseases, is needed. Especially, cautious evaluation in-
cluding electrodiagnosis should be considered in patients pre-
senting with painless weakness. We have previously published 
a study showing that 34 (10.3%) of 331 patients with ALS un-
derwent unnecessary surgery due to a misdiagnosis.11 Another 
Table 3. Operation Sites before Diagnosis of Amyotrophic Lateral Scle-
rosis
Operation site















Cervical spinal operation after carpal 



















Age of symptom onset (yr) 57.5 (15.9) 60.6 (14.1) 66.7 (14.0) 0.012 0.159 0.006 <0.001
Time between symptom onset and 
  diagnosis (months)
10.0 (13.0) 8.5 (10.0) 6.0 (7.0) 0.105 0.204 0.018  0.005
*Median (interquartile range), †p values from Kruskal-Wallis test with Bonferroni correction.
341
Jang Woo Lee, et al.
https://doi.org/10.3349/ymj.2021.62.4.338
study using data from the Korean National Health Insurance 
Service revealed that 41.8% of patients with ALS were misdiag-
nosed with myelopathy and that 5.78% received inappropri-
ate spinal surgery.12 Unlike these previous studies, the present 
study derived the time of symptom development through 
medical records and consequently revealed that inappropri-
ate surgical treatments based on misdiagnosis significantly 
increased the time from symptom onset to diagnosis of ALS. 
Kraemer, et al.4 also reported that improper operations delayed 
the diagnosis of ALS in a study of 100 patients. Misdiagnosis of 
other musculoskeletal diseases at the beginning of ALS and 
inappropriate surgical treatments may lead to suffering, un-
necessary medical expenses, and delays in ALS diagnosis, 
which may prevent indispensable initial treatments and affect 
long-term prognosis.13,14 Because ALS is very rare, symptoms 
of ALS may be difficult to recognize unless the physician is fa-
miliar or experienced with neuromuscular diseases. The char-
acteristics of limb-dominant ALS most commonly involving 
middle-aged people and presenting as focal asymmetric limb 
weakness at an initial stage can often be confused with degen-
erative spinal diseases.15,16 The bulbar-dominant type is known 
to be related to a shorter duration between onset and diagno-
sis, compared to the limb-dominant type.4,17,18 Generally, it is 
hard to suspect musculoskeletal disorders, including spinal 
diseases, which require surgical treatment, as a cause of bulbar 
symptoms.3 In this study, 95.3% of the patients who received in-
appropriate operations also had limb-dominant onset. In fact, 
musculoskeletal diseases have been considered as a priority 
in many patients with initial presentation of limb-related 
symptoms. Nzwalo, et al.3 reported that the diagnosis of ALS 
was faster when the initial consultation doctor was a neurolo-
gist, compared with other specialist doctors. Based on these 
results, diagnostic evaluations, such as imaging studies, elec-
trodiagnosis, and genetic tests, are required in patients with 
suspected symptoms of ALS, so that the diagnosis of ALS can 
be accelerated and unnecessary treatments can be avoided. 
Generally, patients with ALS are classified into limb-domi-
nant and bulbar-dominant types according to the initial pre-
sentation, and limb-dominant onset is known to be more com-
mon than bulbar-dominant onset.19 In addition, in this study, 
limb-dominant onset was about 2.3 times more frequent than 
bulbar-dominant onset. However, respiratory-dominant on-
set accounted for a non-negligible rate of 4.2%, in addition to 
limb- and bulbar-dominant onset. Although dyspnea can be 
an initial presenting symptom in patients with ALS, ventilatory 
insufficiency is known to be very rare.20,21 In a small group of 
patients, trunk or respiratory involvement may occur early in 
the disease,22 although there is insufficient clinical data on 
this: a few studies have reported on the actual rate of initial re-
spiratory involvement among all patients. In the studies by 
Paganoni, et al.23 and Gautier, et al.,24 1.6% (5 of 304 patients) 
and 3.0% (17 of 573 patients) showed respiratory symptoms 
as initial symptoms of ALS, respectively. Shoesmith, et al.25 re-
ported that 2.7% (21 of 791 patients) had initial respiratory 
symptoms in their retrospective chart review. Among 21 pa-
tients with respiratory-dominant onset, 76% were male. and 
the median age of symptom onset was relatively higher at 68.5 
years, similar to that in our study. de Cavalho, et al.26 analyzed 
29 patients presenting with initial ventilatory insufficiency, 
comprising four of their cases and 25 patients from 16 previ-
ous case reports. The average age of these patients was 62.7 
years, which was younger than that in studies by our group 
and Shoesmith, et al.,25 and 86.2% (n=25) of them were male. 
In a study by Gautier, et al.,24 all 17 patients with respiratory-
dominant onset were male as well. Our study differs from pre-
vious studies in that we directly compared the clinical demo-
graphics of different clinical types with patients with initial 
respiratory symptoms. Although the reason remains unknown, 
it is believed that there is a male predominance for respiratory-
dominant onset, and the onset age tends to be relatively higher, 
compared to the other types. In addition, in 71.4% of patients 
with respiratory-dominant onset in our study, emergent place-
ment of endotracheal intubation was required. This is differ-
ent from the study of Shoesmith, et al.,25 in which only 14.3% (3 
of 21) of the patients needed endotracheal intubation. Howev-
er, in many case reports, mechanical ventilatory support was 
required in the early stages of the disease in patients who pre-
sented with initial respiration-related symptoms,26 and emer-
gent endotracheal intubation was also needed prior to the diag-
nosis of ALS, as in our study.27,28 In a large-scale study, it was 
reported that the period from symptom onset to non-invasive 
ventilation was shorter in patients with respiratory onset, com-
pared to that in other types.24 Therefore, it is considered that 
prognosis related to the ventilation is poor in patients with ear-
ly respiratory symptoms.
If a patient complains of respiratory difficulty, generally the 
physician considers cardiologic or pulmonary problems first. 
Dyspnea is also likely to be regarded as a kind of aging process, 
like distal limb weakness derived from a degenerative spinal 
disease. Furthermore, because the onset age of the respiratory-
dominant type is relatively higher than that of other types, it is 
possible that ALS might not be considered at the initial pre-
sentation in many cases. However, the diagnosis of ALS may 
be accelerated during the course of various treatments and di-
agnostic evaluations: indeed, the disease progressed quickly 
in 15 of 21 (71.4%) patients who showed rapid deterioration of 
respiratory function requiring emergent endotracheal intuba-
tion in our study. The patients with respiratory-dominant on-
set were all male and had exceptionally short durations from 
symptom onset to diagnosis. When male patients with respi-
ratory-dominant onset were excluded, however, there was no 
longer a difference between sexes in the time between symp-
tom onset to diagnosis. The disease had progressed rapidly in 
this patient group, and during the treatment for rapid deterio-
ration of ventilatory insufficiency, various tests might have 
been performed resulting in a quicker diagnosis. Although the 
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diagnosis was significantly faster in patients with respiratory-
dominant onset than patients with other types, considering the 
occurrence of sudden ventilatory failure and consequent emer-
gent intubation, it is thought that earlier diagnosis is needed in 
these patients. Therefore, attention needs to be paid to respira-
tory symptoms, of which the causes are unknown. Detailed his-
tory taking and a meticulous physical examination are also 
required. Because medical information is deficient and the 
reasons for male predominance and older age of respiratory-
dominant onset are still unclear, epidemiological studies and 
further investigations are required.
A few limitations warrant consideration. Recall bias may have 
occurred because the information of onset time and symptoms 
depended heavily on the patients’ memories. Even though 
medical data were gathered at a single institution, the initial 
evaluation and treatments were carried out at different hospi-
tals, and medical staff at the patients’ first visits also varied. 
Therefore, the treatments and diagnostic workups would have 
differed depending on the medical institution and doctors that 
the patients visited. Furthermore, because access was limited, 
progress of diagnostic evaluation, especially related to opera-
tions in other hospitals, could not be verified. Since only the 
time from symptom onset to diagnosis was analyzed, a follow-
up study on the long-term outcomes of patients with different 
clinical types is needed.
In conclusion, unnecessary surgical treatments due to mis-
diagnosis at an early disease stage significantly delay the diag-
nosis of ALS. In particular, because limb-dominant onset is 
often misdiagnosed as a musculoskeletal disease, especially 
of spinal origin in many cases, detailed surveillance, including 
close history taking, physical examination, and diagnostic eval-
uations, such as electrodiagnosis, is required. Respiratory dif-
ficulty can be another initial presentation of ALS accounting 
for an appreciable number of cases, in addition to the limb- 
and bulbar-dominant types. Finally, compared to the limb- or 
bulbar-dominant type, the respiratory-dominant onset type 
showed male predominance, older age at onset of symptoms, 
and poor prognosis.
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